Cancer and Myotonic Dystrophy

There have been reports of increased cancer risk in patients with Myotonic Dystrophy. another study was just published highlighting the risk of cancer in this disease. The conclusion of the study was 


Conclusion: There is an increased risk of death, and probably cancer, in relatives with DM1 and in those whose DM1 status is unknown. This suggests a
need to perform a careful history and physical examination, supplemented by
genetic testing, to identify family members at risk for DM1 and who might
benefit from disease-specific clinical care and surveillance.


Print Friendly, PDF & Email

Care recommendations for patients with myotonic dystrophy

Published in 2018 is a consensus based approach for the myotonic dystrophy patient community. This gives general guidelines on how to approach, test and intervene in patients lives to achieve the most optimum outcomes.


Print Friendly, PDF & Email

Increased cancer risk for patients with myotonic dystrophy

Conclusion: Patients with myotonic dystrophy may have an increased risk of thyroid cancer and choroidal melanoma
and, possibly, testicular and prostate cancers.


Print Friendly, PDF & Email